Zusammenfassung
Diabetes mellitus ist ein erhebliches Gesundheitsproblem mit steigender Prävalenz weltweit, mitbedingt durch Bewegungsmangel, Übergewicht und eine Verdreifachung des Zuckerkonsums in den letzten 50 Jahren. Die Stoffwechselerkrankung geht mit verschiedenen Komorbiditäten einher, wobei die Auswirkungen auf die Lunge zwar zunehmend untersucht werden, allerdings im klinischen Alltag oft noch unbeachtet bleiben. Der Beitrag liefert einen kurzen Überblick zur Diagnostik und Therapie der verschiedenen Formen des Diabetes für Pneumologen. Zudem werden der Einfluss der Diabeteserkrankung auf Lungenfunktion und Bildgebung sowie wichtige Wechselwirkungen mit pneumologischen Krankheiten aufgezeigt.
Abstract
Diabetes mellitus (DM) is a major health problem with increasing prevalence worldwide that is associated with a sedentary lifestyle, overweight and a tripling of sugar consumption over the last 50 years. This metabolic disease is associated with various comorbidities. There is increasing data about the effects of DM on the lung; however, this is rarely taken into account in clinical practice. The article gives a brief overview of the diagnosis and treatment of the distinct forms of DM for the pneumologist. The influence of diabetes on lung function and imaging as well as important interactions with pulmonary diseases are presented.
Literatur
Lustig RH, Schmidt LA, Brindis CD (2012) Public health: The toxic truth about sugar. Nature 482(7383):27–29
Muller-Wieland D, Marx N (2017) Diabetology as an interdisciplinary challenge. Internist (Berl) 58(4):329–335
da Rocha Fernandes J, Ogurtsova K, Linnenkamp U et al (2016) IDF Diabetes Atlas estimates of 2014 global health expenditures on diabetes. Diabetes Res Clin Pract 117:48–45
Cameron AT (1932) The effect of smoking on the blood sugar. Can Med Assoc J 27(4):421–422
Sandler M, Bunn AE, Stewart RI (1986) Pulmonary function in young insulin-dependent diabetic subjects. Chest 90(5):670–675
Walter RE, Beiser A, Givelber RJ, O’Connor GT, Gottlieb DJ (2003) Association between glycemic state and lung function: the Framingham Heart Study. Am J Respir Crit Care Med 167(6):911–916
Müller-Wieland D, Petermann A, Nauck M et al (2016) Definition, Klassifikation und Diagnostik des Diabetes mellitus; DDG Praxisempfehlung. Diabetologie 11(Suppl 2):S78–S81
Böhm BO, Dreyer M, Fritsche A et al (2016) Therapie des Typ-1-Diabetes; Kurzfassung 1. Auflage DDG Praxisempfehlung. Diabetologie 11(Suppl 2):S106–S16
Stefan N, Fritsche A, Schick F, Haring HU (2016) Phenotypes of prediabetes and stratification of cardiometabolic risk. Lancet Diabetes Endocrinol 4(9):789–798
Liu XX, Zhu XM, Miao Q, Ye HY, Zhang ZY, Li YM (2014) Hyperglycemia induced by glucocorticoids in nondiabetic patients: a meta-analysis. Ann Nutr Metab 65(4):324–332
Burt MG, Roberts GW, Aguilar-Loza NR, Frith P, Stranks SN (2011) Continuous monitoring of circadian glycemic patterns in patients receiving prednisolone for COPD. J Clin Endocrinol Metab 96(6):1789–1796
Hackman KL, Snell GI, Bach LA (2016) Poor glycemic control is associated with decreased survival in lung transplant recipients. Transplantation. doi:10.1097/tp.0000000000001555
Willms A, Schumm-Draeger P‑M, Siegmund T (2016) Glukokortikoide und Diabetes. Diabetologe 12:127–138
Hayes D Jr., Patel AV, Black SM et al (2015) Influence of diabetes on survival in patients with cystic fibrosis before and after lung transplantation. J Thorac Cardiovasc Surg 150(3):707–713
Lange P, Parner J, Schnohr P, Jensen G (2002) Copenhagen City Heart Study: longitudinal analysis of ventilatory capacity in diabetic and nondiabetic adults. Eur Respir J 20(6):1406–1412
van den Borst B, Gosker HR, Zeegers MP, Schols AM (2010) Pulmonary function in diabetes: a metaanalysis. Chest 138(2):393–406
Schuyler MR, Niewoehner DE, Inkley SR, Kohn R (1976) Abnormal lung elasticity in juvenile diabetes mellitus. Am Rev Respir Dis 113(1):37–41
Stubbe B, Schipf S, Schaper C et al (2017) The influence of type 1 diabetes mellitus on pulmonary function and exercise capacity – results from the Study of Health in Pomerania (SHIP). Exp Clin Endocrinol Diabetes 125(1):64–69
Wanke T, Formanek D, Auinger M, Popp W, Zwick H, Irsigler K (1991) Inspiratory muscle performance and pulmonary function changes in insulin-dependent diabetes mellitus. Am Rev Respir Dis 143(1):97–100
Varechova S, Durdik P, Cervenkova V, Ciljakova M, Banovcin P, Hanacek J (2007) The influence of autonomic neuropathy on cough reflex sensitivity in children with diabetes mellitus type 1. J Physiol Pharmacol 58(Suppl 5(Pt 2)):705–715
Santos e Fonseca CM, Manco JC, Gallo Junior L, Barreira AA, Foss MC (1992) Cholinergic bronchomotor tone and airway caliber in insulin-dependent diabetes mellitus. Chest 101(4):1038–1043
Pitocco D, Fuso L, Conte EG et al (2012) The diabetic lung – a new target organ? Rev Diabet Stud 9(1):23–35
Yeh HC, Punjabi NM, Wang NY, Pankow JS, Duncan BB, Brancati FL (2005) Vital capacity as a predictor of incident type 2 diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care 28(6):1472–1479
Ford ES, Mannino DM, National H (2004) Prospective association between lung function and the incidence of diabetes: findings from the national health and Nutrition Examination Survey Epidemiologic Follow-up Study. Diabetes Care 27(12):2966–2970
Durdik P, Vojtkova J, Michnova Z et al (2016) Pulmonary function tests in type 1 diabetes adolescents with diabetic cardiovascular autonomic neuropathy. J Diabetes Complications 30(1):79–84
Lopez-Lopez JG, Moral-Sanz J, Frazziano G et al (2008) Diabetes induces pulmonary artery endothelial dysfunction by NADPH oxidase induction. Am J Physiol Lung Cell Mol Physiol 295(5):L727–32
Dennis RJ, Maldonado D, Rojas MX et al (2010) Inadequate glucose control in type 2 diabetes is associated with impaired lung function and systemic inflammation: a cross-sectional study. BMC Pulm Med 10:38
Ofulue AF, Thurlbeck WM (1988) Experimental diabetes and the lung. II. In vivo connective tissue metabolism. Am Rev Respir Dis 138(2):284–289
Kent BD, McNicholas WT, Ryan S (2015) Insulin resistance, glucose intolerance and diabetes mellitus in obstructive sleep apnoea. J Thorac Dis 7(8):1343–1357
Aronsohn RS, Whitmore H, Van Cauter E, Tasali E (2010) Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes. Am J Respir Crit Care Med 181(5):507–513
Das S, Pal S, Mitra M (2016) Significance of exhaled breath test in clinical diagnosis: a special focus on the detection of diabetes mellitus. J Med Biol Eng 36(5):605–624
Pedersen BK, Saltin B (2015) Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases. Scand J Med Sci Sports 25(Suppl 3):1–72
Piepoli MF, Corra U, Agostoni P (2017) Cardiopulmonary exercise testing in heart failure patients with specific comorbidities. Ann Am Thorac Soc. doi:10.1513/annalsats.201610-803fr
Tunkamnerdthai O, Auvichayapat P, Donsom M, Leelayuwat N (2015) Improvement of pulmonary function with arm swing exercise in patients with type 2 diabetes. J Phys Ther Sci 27(3):649–654
Hashimoto H, Iijima K, Hashimoto M et al (2009) Validity and usefulness of aortic arch calcification in chest X‑ray. J Atheroscler Thromb 16(3):256–264
Hersh CP, Make BJ, Lynch DA et al (2014) Non-emphysematous chronic obstructive pulmonary disease is associated with diabetes mellitus. BMC Pulm Med 14:164
Ikezoe J, Takeuchi N, Johkoh T et al (1992) CT appearance of pulmonary tuberculosis in diabetic and immunocompromised patients: comparison with patients who had no underlying disease. AJR Am J Roentgenol 159(6):1175–1179
Song Q, Zhang G, Jiang H, Ren Y, Lu X (2016) Imaging features of pulmonary CT in type 2 diabetic patients with multidrug-resistant tuberculosis. PLoS ONE 11(3):e0152507
Spiegel K, Leproult R, Van Cauter E (1999) Impact of sleep debt on metabolic and endocrine function. Lancet 354(9188):1435–1439
Kent BD, Grote L, Ryan S et al (2014) Diabetes mellitus prevalence and control in sleep-disordered breathing: the European Sleep Apnea Cohort (ESADA) study. Chest 146(4):982–990
Lecube A, Ciudin A, Sampol G, Valladares S, Hernandez C, Simo R (2015) Effect of glycemic control on nocturnal arterial oxygen saturation: a case-control study in type 2 diabetic patients. J Diabetes 7(1):133–138
Tosca MA, Silovestri M, D’Annunzio G, Lorini R, Rossi GA, Ciprandi G (2013) May T1 diabetes mellitus protect from asthma? Allergol Immunopathol (Madr) 41(5):288–291
Yun HD, Knoebel E, Fenta Y et al (2012) Asthma and proinflammatory conditions: a population-based retrospective matched cohort study. Mayo Clin Proc 87(10):953–960
Forno E, Han YY, Muzumdar RH, Celedon JC (2015) Insulin resistance, metabolic syndrome, and lung function in US adolescents with and without asthma. J Allergy Clin Immunol 136(2):304–311.e8
Koskela HO, Salonen PH, Romppanen J, Niskanen L (2015) A history of diabetes but not hyperglycaemia during exacerbation of obstructive lung disease has impact on long-term mortality: a prospective, observational cohort study. BMJ Open 5(1):e006794
Fleixo-Lima G, Ventura H, Medini M, Bar L, Strauss P, Lewis EC (2014) Mechanistic evidence in support of alpha1-antitrypsin as a therapeutic approach for type 1 diabetes. J Diabetes Sci Technol 8(6):1193–1203
Lee JY, Jeon I, Lee JM, Yoon JM, Park SM (2013) Diabetes mellitus as an independent risk factor for lung cancer: a meta-analysis of observational studies. Eur J Cancer 49(10):2411–2423
Leduc C, Antoni D, Charloux A, Falcoz PE, Quoix E (2017) Comorbidities in the management of patients with lung cancer. Eur Respir J 49(3):1601721
Medairos RA, Clark J, Holoubek S et al (2016) Metformin exposure is associated with improved progression-free survival in diabetic patients after resection for early-stage non-small cell lung cancer. J Thorac Cardiovasc Surg 152(1):55–61
Hansmann G, Wagner RA, Schellong S et al (2007) Pulmonary arterial hypertension is linked to insulin resistance and reversed by peroxisome proliferator-activated receptor-gamma activation. Circulation 115(10):1275–1284
Movahed MR, Hashemzadeh M, Jamal MM (2005) The prevalence of pulmonary embolism and pulmonary hypertension in patients with type II diabetes mellitus. Chest 128(5):3568–3571
Lepper PM, Ott S, Nuesch E et al (2012) Serum glucose levels for predicting death in patients admitted to hospital for community acquired pneumonia: prospective cohort study. BMJ 344:e3397
Jimenez-Trujillo I, Jimenez-Garcia R, de Miguel-Diez J et al (2017) Incidence, characteristic and outcomes of ventilator-associated pneumonia among type 2 diabetes patients: An observational population-based study in Spain. Eur J Intern Med 40:72–78
Riza AL, Pearson F, Ugarte-Gil C et al (2014) Clinical management of concurrent diabetes and tuberculosis and the implications for patient services. Lancet Diabetes Endocrinol 2(9):740–753
Girardi E, Sane Schepisi M, Goletti D et al (2017) The global dynamics of diabetes and tuberculosis: the impact of migration and policy implications. Int J Infect Dis 56:45–53
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
H. Wilkens und D. Leser geben an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.
Additional information
Redaktion
F. J. Meyer, München
H. Wilkens, Homburg/Saar
Rights and permissions
About this article
Cite this article
Wilkens, H., Leser, D. Diabetes und Lunge. Pneumologe 14, 219–227 (2017). https://doi.org/10.1007/s10405-017-0122-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10405-017-0122-1